147 related articles for article (PubMed ID: 34227275)
1. Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation.
Lee OH; Kim YD; Kim JS; Son NH; Pak HN; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jung YH; Choi HY; Lee KY; Cho BH; Han SW; Park JH; Cho HJ; Park HJ; Nam HS; Heo JH; So CY; Cheung GSH; Lam YY; Freixa X; Tzikas A; Jang Y; Park JW
Korean Circ J; 2021 Jul; 51(7):626-638. PubMed ID: 34227275
[TBL] [Abstract][Full Text] [Related]
2. Favorable neurological outcome after ischemic cerebrovascular events in patients treated with percutaneous left atrial appendage occlusion compared with warfarin.
Lee OH; Kim YD; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Freixa X; Tzikas A; Heo JH; Jang Y; Park JW
Catheter Cardiovasc Interv; 2019 Jul; 94(1):E23-E29. PubMed ID: 30280479
[TBL] [Abstract][Full Text] [Related]
3. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
Besola L; Gregori D; Fiocco A; Colli A
Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
[TBL] [Abstract][Full Text] [Related]
5. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 33858727
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk.
Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M
EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience.
Xipell M; Flores-Umanzor E; Ojeda R; Arias M; Cepas-Guillén PL; Regueiro A; Freixa X; Cases A; Maduell F
Artif Organs; 2020 May; 44(5):513-521. PubMed ID: 31715006
[TBL] [Abstract][Full Text] [Related]
8. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
[TBL] [Abstract][Full Text] [Related]
9. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry.
Cruz-González I; González-Ferreiro R; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Kanagaratnam P; Nietlispach F; Gloekler S; Aminian A; Danna P; Rezzaghi M; Stock F; Stolcova M; Paiva L; Costa M; Millán X; Ibrahim R; Tichelbäcker T; Schillinger W; Park JW; Sievert H; Meier B; Tzikas A
Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):28-34. PubMed ID: 31036510
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.
Freixa X; Llull L; Gafoor S; Cruz-Gonzalez I; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Kanagaratnam P; Nietlispach F; Gloekler S; Aminian A; Danna P; Rezzaghi M; Stock F; Stolcova M; Paiva L; Costa M; Millán X; Ibrahim R; Tichelbäcker T; Schillinger W; Park JW; Sievert H; Meier B; Tzikas A
Am J Cardiol; 2016 Dec; 118(12):1836-1841. PubMed ID: 27745964
[TBL] [Abstract][Full Text] [Related]
11. A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation.
Micieli A; Wijeysundera HC; Qiu F; Atzema CL; Singh SM
Med Decis Making; 2016 Apr; 36(3):366-74. PubMed ID: 26139448
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous devices for left atrial appendage occlusion: A contemporary review.
Moussa Pacha H; Al-Khadra Y; Soud M; Darmoch F; Moussa Pacha A; Alraies MC
World J Cardiol; 2019 Feb; 11(2):57-70. PubMed ID: 30820276
[TBL] [Abstract][Full Text] [Related]
13. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
[TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region.
Tay E; Paul B; Sharp J; Wang D; Chui ASF; Hazra PK; Santoso T; Albers B; Diener HC; Lewalter T; Wong A
J Interv Card Electrophysiol; 2021 Aug; 61(2):269-281. PubMed ID: 32588371
[TBL] [Abstract][Full Text] [Related]
15. Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation-One-Year Survival.
Tiosano S; Banai A; Mulla W; Goldenberg I; Bayshtok G; Amit U; Shlomo N; Nof E; Rosso R; Glikson M; Guetta V; Barbash I; Beinart R
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892833
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
17. Association of Hospital Procedural Volume With Outcomes of Percutaneous Left Atrial Appendage Occlusion.
Nazir S; Ahuja KR; Kolte D; Isogai T; Michihata N; Saad AM; Ramanathan PK; Krishnaswamy A; Wazni OM; Saliba WI; Gupta R; Kapadia SR
JACC Cardiovasc Interv; 2021 Mar; 14(5):554-561. PubMed ID: 33663783
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.
Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719
[TBL] [Abstract][Full Text] [Related]
19. Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real-world experience from a tertiary care hospital.
Margonato D; Preda A; Ingallina G; Rizza V; Fierro N; Radinovic A; Ancona F; Patti G; Agricola E; Bella PD; Mazzone P
J Arrhythm; 2023 Jun; 39(3):395-404. PubMed ID: 37324751
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kook H; Kim HD; Shim J; Kim YH; Kim JS; Pak HN; Lee HJ; Choi RK; Kang WC; Shin ES; Park JW; Yu CW; Lim DS
PLoS One; 2021; 16(1):e0244723. PubMed ID: 33411816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]